| Literature DB >> 34848537 |
Benjamin R Baer1, Mario Gaudino2, Mary Charlson3, Stephen E Fremes4,5, Martin T Wells6,3.
Abstract
The fragility index is a clinically meaningful metric based on modifying patient outcomes that is increasingly used to interpret the robustness of clinical trial results. The fragility index relies on a concept that explores alternative realizations of the same clinical trial by modifying patient measurements. In this article, we propose to generalize the fragility index to a family of fragility indices called the incidence fragility indices that permit only outcome modifications that are sufficiently likely and provide an exact algorithm to calculate the incidence fragility indices. Additionally, we introduce a far-reaching generalization of the fragility index to any data type and explain how to permit only sufficiently likely modifications for nondichotomous outcomes. All of the proposed methodologies follow the fragility index concept.Entities:
Keywords: P value; evidence measure; fragility index; interpretability; statistical significance
Mesh:
Year: 2021 PMID: 34848537 PMCID: PMC8670515 DOI: 10.1073/pnas.2105254118
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 12.779